Objectives To assess the effect of treatment on haemostatic parameters in patients with early rheumatoid arthritis (RA).

Patients with late-onset rheumatoid arthritis face poorer physical outcomes and higher risks of death and malignancy, ...

MyMD-1 is under clinical development by TNF Pharmaceuticals and currently in Phase I for Hashimoto Thyroiditis.

Though researchers still don’t know what causes the disorder, studies show that people with fibromyalgia have an increased ...

Zegocractin is under clinical development by CalciMedica and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia.

High serum CXCL13 levels are predictive of treatment failure with first-line MTX among patients with early RA.

Differences in rates of bDMARD treatment initiation among US veterans with RA living in rural vs urban areas cannot be fully explained by location.

The presence of CVD may increase the risk of developing dementia among older patients with RA, though CVD was not found to ...

Moderate alcohol consumption and eating oily fish, fruits, and cereals may reduce the risk for rheumatoid arthritis.

Patients with early RA who did not require a biologic disease-modifying antirheumatic drug (DMARD) had a higher chance of ...

Now, scientists at Stanford University have found that a faulty genetic molecule could be responsible for the immune system misidentifying healthy tissue as a threat. The breakthrough study, published ...

INR:3015. bdm cricket bat Junshi Biosciences' new indication application for Teplizumab has been accepted Analysis of the current status of rheumatoid biologics: ...